Italy ends Aspen pharma monitoring
Italy’s competition authority has ended its investigation into Aspen, concluding that the drugmaker has complied with price regulations imposed since its €5 million fine in 2016.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.